Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Protagonist Therapeutics, Inc Transaction History
Commonwealth Of Pennsylvania Public School Empls Retrmt Sys
- $15.7 Billion
- Q4 2024
A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 12,723 shares of PTGX stock, worth $493,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,723
Previous 12,591
1.05%
Holding current value
$493,016
Previous $565,000
13.1%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTGX
# of Institutions
254Shares Held
58.9MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$230 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$223 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$213 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$164 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$129 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.9B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...